CRYO-CELL INTERNATIONAL, INC. (CCEL) Quick Ratio
- Quick ratio · latest quarter: Value 0.63×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-05-31..
Quick ratio
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 0.63× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-05-31. $10.07M ÷ $15.93M ≈ 0.63× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 10.07M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 15.93M USD | Liabilities, Current |
| Cash and equivalents | 507.30K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 2.65M USD | Marketable Securities, Current |
| Customer receivables | 6.91M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 310.17K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $10.07M | $15.93M | $507.30K | $2.65M | $6.91M | $310.17K | 0.63× |
| 2026-02-28 | $9.72M | $17.76M | $249.67K | $2.65M | $6.82M | $356.99K | 0.55× |
| 2025-11-30 | $10.14M | $19.79M | $319.03K | $2.98M | $6.85M | $408.79K | 0.51× |
| 2025-08-31 | $10.05M | $18.45M | $265.21K | $2.96M | $6.83M | $655.25K | 0.54× |
| 2025-05-31 | $11.36M | $21.75M | $137.49K | $4.29M | $6.93M | $676.76K | 0.52× |
| 2025-02-28 | $10.69M | $21.72M | $223.12K | $3.26M | $7.21M | $730.47K | 0.49× |
| 2024-11-30 | $10.81M | $21.60M | $560.96K | $2.94M | $7.31M | $657.70K | 0.50× |
| 2024-08-31 | $9.00M | $17.42M | $197.44K | $1.93M | $6.87M | $731.36K | 0.52× |
| 2024-05-31 | $8.36M | $19.45M | $469.19K | $1.06M | $6.83M | $708.19K | 0.43× |
| 2024-02-29 | $7.71M | $19.37M | $247.11K | $732.48K | $6.73M | $755.16K | 0.40× |
| 2023-11-30 | $7.56M | $20.86M | $406.07K | $574.18K | $6.58M | $768.88K | 0.36× |
| 2023-08-31 | $7.65M | $18.56M | $584.00K | $623.49K | $6.44M | $1.06M | 0.41× |
| 2023-05-31 | $8.37M | $19.71M | $1.12M | $568.18K | $6.68M | $879.29K | 0.42× |
| 2023-02-28 | $8.74M | $18.91M | $1.37M | $840.28K | $6.52M | $900.05K | 0.46× |
| 2022-11-30 | $7.77M | $19.48M | $1.70M | $17.62K | $6.04M | $851.23K | 0.40× |
| 2022-08-31 | $8.31M | $23.62M | $2.92M | $38.70K | $5.35M | $919.27K | 0.35× |
| 2022-05-31 | $8.02M | $15.71M | $2.80M | $63.13K | $5.15M | $873.16K | 0.51× |
| 2022-02-28 | $7.77M | $16.39M | $2.14M | $472.37K | $5.15M | $927.57K | 0.47× |
| 2021-11-30 | $13.59M | $21.07M | $8.26M | $75.41K | $5.25M | $921.21K | 0.64× |
| 2021-08-31 | $13.22M | $19.86M | $7.70M | $74.12K | $5.45M | $833.96K | 0.67× |
| 2021-05-31 | $13.24M | $20.12M | $7.95M | $73.39K | $5.22M | $890.39K | 0.66× |
| 2021-02-28 | $17.00M | $29.84M | $11.28M | $85.90K | $5.64M | $868.26K | 0.57× |
| 2020-11-30 | $16.77M | $16.41M | $10.36M | $88.48K | $6.32M | $927.32K | 1.02× |
| 2020-08-31 | $14.67M | $14.43M | $8.11M | $62.72K | $6.50M | $1.20M | 1.02× |
| 2020-05-31 | $15.30M | $15.10M | $8.42M | $905.43K | $5.97M | $1.05M | 1.01× |
| 2020-02-29 | $15.14M | $16.07M | $8.42M | $959.00K | $5.77M | $1.10M | 0.94× |
| 2019-11-30 | $13.54M | $15.43M | $6.54M | $904.05K | $6.10M | $1.08M | 0.88× |
| 2019-08-31 | $14.10M | $14.27M | $7.34M | $874.69K | $5.89M | $1.03M | 0.99× |
| 2019-05-31 | $13.07M | $13.61M | $6.47M | $839.81K | $5.76M | $1.05M | 0.96× |
| 2019-02-28 | $13.58M | $15.28M | $7.08M | $808.51K | $5.69M | $16.13M | 0.89× |
| 2018-11-30 | $12.78M | $15.43M | $6.04M | $875.69K | $5.87M | $16.04M | 0.83× |
| 2018-08-31 | $13.50M | $14.91M | $7.04M | $949.76K | $5.51M | $16.17M | 0.91× |
| 2018-05-31 | $11.93M | $12.80M | $6.54M | $572.61K | $4.82M | $424.49K | 0.93× |
| 2018-02-28 | $12.51M | $13.31M | $6.99M | $586.23K | $4.93M | $374.44K | 0.94× |
| 2017-11-30 | $11.84M | $13.94M | $6.28M | $439.32K | $5.13M | $314.57K | 0.85× |
| 2017-08-31 | $10.05M | $12.60M | $4.67M | $523.88K | $4.86M | $335.76K | 0.80× |
| 2017-05-31 | $9.73M | $12.98M | $4.70M | $478.34K | $4.56M | $296.26K | 0.75× |
| 2017-02-28 | $8.43M | $12.59M | $3.51M | $476.46K | $4.45M | $285.96K | 0.67× |
| 2016-11-30 | $8.18M | $13.11M | $3.50M | $624.22K | $4.05M | $361.14K | 0.62× |
| 2016-08-31 | $7.04M | $12.41M | $2.03M | $630.02K | $4.38M | $410.88K | 0.57× |
| 2016-05-31 | $8.89M | $10.52M | $4.52M | $673.78K | $3.70M | $459.58K | 0.85× |
| 2016-02-29 | $7.42M | $10.18M | $3.58M | $617.11K | $3.22M | $498.52K | 0.73× |
| 2015-12-03 | (m) | (m) | $4.15M | (m) | (m) | (m) | (m) |
| 2015-11-30 | $7.82M | $10.42M | $4.15M | $610.42K | $3.06M | $475.61K | 0.75× |
| 2015-08-31 | $7.34M | $10.45M | $2.72M | $460.51K | $4.16M | $539.09K | 0.70× |
| 2015-05-31 | $8.15M | $9.11M | $3.91M | $532.37K | $3.71M | (m) | 0.89× |
| 2015-02-28 | $7.85M | $8.70M | $3.55M | $98.26K | $4.20M | (m) | 0.90× |
| 2014-11-30 | $7.45M | $9.13M | $3.28M | $102.67K | $4.07M | (m) | 0.82× |
| 2014-08-31 | $7.52M | $8.80M | $3.45M | $122.66K | $3.95M | (m) | 0.85× |
| 2014-05-31 | $7.64M | $8.79M | $3.40M | $140.56K | $4.10M | (m) | 0.87× |
| 2014-02-28 | (m) | $8.68M | $3.24M | (m) | $3.70M | (m) | (m) |
| 2013-12-01 | (m) | (m) | $3.93M | (m) | (m) | (m) | (m) |
| 2013-11-30 | (m) | $9.81M | $3.93M | (m) | $3.34M | (m) | (m) |
| 2013-08-31 | (m) | $9.68M | $3.73M | (m) | $3.58M | (m) | (m) |
| 2013-05-31 | (m) | $10.66M | $2.90M | (m) | $3.57M | (m) | (m) |
| 2013-02-28 | (m) | $10.41M | $2.86M | (m) | $3.36M | (m) | (m) |
| 2012-11-30 | (m) | $10.66M | $2.68M | (m) | $3.40M | (m) | (m) |
| 2012-08-31 | (m) | $10.23M | $2.71M | (m) | $3.37M | (m) | (m) |
| 2012-05-31 | (m) | $9.80M | $2.80M | (m) | $3.29M | (m) | (m) |
| 2012-02-29 | (m) | $9.71M | $4.32M | (m) | $3.21M | (m) | (m) |
| 2011-11-30 | $10.37M | $10.56M | $6.31M | $1.00M | $3.06M | (m) | 0.98× |
| 2011-08-31 | $9.44M | $9.73M | $5.87M | $1.00M | $2.57M | (m) | 0.97× |
| 2011-05-31 | (m) | (m) | $8.21M | (m) | (m) | (m) | (m) |
| 2011-02-28 | (m) | (m) | $8.38M | (m) | (m) | (m) | (m) |
| 2010-11-30 | $11.86M | $8.15M | $8.37M | $1.13M | $2.36M | (m) | 1.46× |
| 2010-08-31 | (m) | (m) | $7.88M | (m) | (m) | (m) | (m) |
| 2009-11-30 | (m) | (m) | $6.85M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |